Anemia Clinical Trial
— MUGUST_2Official title:
The Efficacy of a Local Vitamin-C Rich Fruit (Guava) in Improving Iron Absorption From Mungbean Based Meals in Indian Children (6-10 Years)
Iron deficiency is estimated to affect about one fifth of the world's population, and women
and children are among the most severely affected. Evidence is mounting that iron deficiency
anemia adversely affects brain development with measurable effects on children's behavior,
motor development and cognition. In Hisar district of Haryana state, north- India, 58% of
school age children (6-10 years) are anemic, 49 % are iron deficient whereas 40 % have been
found to be anemic due to iron deficiency. Iron bioavailability calculated using algorithms
in regional diets ranged from 3.2 to 4.6 percent. Mungbean (Vigna radiata L.) is the third
most important legume crop of India. It is a high potential legume crop with 4-8 mg of iron
and known as a nutritious and healthy legume. Ascorbic acid is a potent enhancer of iron
absorption in humans which can counteract the inhibitory effect of phytic acid and
polyphenols. Guava is a popular and easily available fruit for this community having 200-
300 mg/100g of ascorbic acid. We will conduct a randomised controlled trial in school age
children (6-10 years) in Haryana state of India, to determine the efficacy of local
vitamin-C rich fruit guava with mungbean based meal on iron status of rural Indian children.
Objective: To assess the effect of mungbean based test meal on iron status (as body iron
stores, defined and calculated by the ratio of serum ferritin and serum transferrin
receptor) of school age children (6-10 years) with and without the consumption of guava, a
vitamin C rich fruit, in a school feeding program for seven months.
Study population: Three hundred school children aged between 6-10 years will be recruited
from two government school of Mangali village situated in Hisar district of Haryana state.
Study design: This intervention study will be carried out in a randomized controlled design.
Main study parameters/endpoints: Primary outcome will be the measurement of body iron stores
(mg/kg of body weight) based on the ratio of serum transferrin receptor to serum ferritin.
Status | Completed |
Enrollment | 300 |
Est. completion date | April 2011 |
Est. primary completion date | April 2011 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 6 Years to 10 Years |
Eligibility |
Inclusion Criteria: - School children (6-10) years of age - Enrolled in selected primary schools - Informed consent obtained from at least one parent or guardian - Children should be apparently healthy; i.e. have no pre-existing medical conditions or be receiving chronic medication. - Should not be allergic / hypersensitive to any of the ingredients of the test meal - Should not consume mineral/vitamin supplements. If the child consume supplements he/she will be asked to stop taking the supplements two weeks before the study and during the study Exclusion Criteria: - Subjects with severe anemia (Hb=70 g/L)will be referred for treatement at the local health facility. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
India | CCS Haryana Agricultural University | Hisar | Haryana State |
Lead Sponsor | Collaborator |
---|---|
Wageningen University | CCS Haryana Agricultural University Hisar, India |
India,
Rani, V., Brouwer, Inge., Khetarpaul, N., Zimmerman, M.B. (2009) Iron status and associated factors in rural school going children (5-8 years) of Haryana state, India., Abstract Book Wageningen Nutritional Sciences Forum March 4-6, 2009 European Journal of Clinical Nutrition, 63 (3S) Pp:20
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Body Iron Stores | Defined as the ration between serum ferritin and soluble serum transferrin recpetor Body iron stores are a sensitive measure of body iron balance and indicative of body iron changes. | Baseline (Start month=0), End of study (Month=7) | No |
Secondary | Prevalence of iron deficiency, Prevalence of Iron deficiency anemia | Anemia will be defined as a hemoglobin concentration <11.5g/L and iron deficiency will be defined as an SF concentration <12µg/l. | Begin (Month=0), End (Month=7) | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00801931 -
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
|
Phase 1/Phase 2 | |
Completed |
NCT02948283 -
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
|
Phase 1 | |
Completed |
NCT03341338 -
Genes-in-Action - Hepcidin Regulation of Iron Supplementation
|
||
Completed |
NCT00060398 -
Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
|
Phase 3 | |
Recruiting |
NCT05384691 -
Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions
|
Phase 2 | |
Not yet recruiting |
NCT06309641 -
Methemoglobinemia Following Intravenous Iron Treatment
|
||
Completed |
NCT02912533 -
A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
|
Phase 3 | |
Completed |
NCT02912494 -
A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
|
Phase 3 | |
Completed |
NCT03822884 -
Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT02930850 -
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
|
N/A | |
Completed |
NCT02888171 -
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
|
N/A | |
Completed |
NCT02603250 -
Evaluation of Hemoglobin Measurement Tools for Child Anemia Screening in Rwanda
|
N/A | |
Completed |
NCT02384122 -
Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias
|
Phase 3 | |
Completed |
NCT02176759 -
Iron Absorption From Rice Fortified With Ferric Pyrophosphate
|
N/A | |
Completed |
NCT02310113 -
Transfusion and Skeletal Muscle Tissue Oxygenation
|
N/A | |
Withdrawn |
NCT01934842 -
A Study to Compare Analyte Levels in Blood Collected Using an Investigational Collection Device With a Commercial Predicate
|
N/A | |
Completed |
NCT01922479 -
Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure
|
Phase 4 | |
Completed |
NCT01693029 -
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
|
Phase 3 | |
Completed |
NCT01432717 -
Study of ACE-536 in Healthy Postmenopausal Women
|
Phase 1 | |
Terminated |
NCT01535781 -
Study of the Effect of Tranexamic Acid Administered to Patients With Hip Fractures. Can Blood Loss be Reduced?
|
N/A |